PATENT CLAIM ANALYSIS

Application Number: 15883055
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["514", "183000"]

Abstract:
Phthalazinediones that function as intracellular redox modulators in the redox therapy of certain stressed cells are provided. By buffering aberrant redox states, phthalazinediones enable cellular processes essential for survival and augment medical treatments. The phthalazinediones of the invention can modulate functions related to cell growth, differentiation, activity, or death, to correct aberrations and restore homeostasis, and can serve as adjunctive therapy in treating various disease conditions.

Claim (Index 14):
A method of administering to a subject the pharmaceutical composition of  claim 11 .

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.33929
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11199394', '12025193', '12709108', '13764365', '14615704']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8165781800584723
- 35 USC 102 Novelty (BERT): 0.539350833219112
- Combined Prediction Score: 0.7888554453745362
- Mean Citation Score: 355.13245199999994
- Max Citation Score: 387.61838
- Similarity Product: 258.21285165479185

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test